Fructooligosaccharides (FOS) für Irritable Bowel Syndrome (IBS)

Q: Does Fructooligosaccharides (FOS) help with Irritable Bowel Syndrome (IBS)?

Based on 2 studies with 150 participants, there is preliminary evidence that needs more research that Fructooligosaccharides (FOS) may support Irritable Bowel Syndrome (IBS) management. Our evidence grade is D (Very Early Research).

Q: How much Fructooligosaccharides (FOS) should I take for Irritable Bowel Syndrome (IBS)?

Studies have used various dosages. A commonly studied range is 2-10 g/day. Always consult your healthcare provider before starting any supplement regimen.

Q: Are there side effects of Fructooligosaccharides (FOS)?

Reported side effects may include Gas, bloating, and flatulence (dose-dependent; more common above 10 g/day), Abdominal cramping at higher doses, May worsen IBS symptoms in FODMAP-sensitive individuals, Loose stools at excessive doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

Q: How strong is the evidence for Fructooligosaccharides (FOS) and Irritable Bowel Syndrome (IBS)?

We rate the evidence as Grade D (Very Early Research). This rating is based on 2 peer-reviewed studies with 150 total participants. The overall direction of effect is mixed.

Mixed results. Low doses may help (5 g) but higher doses can worsen bloating due to rapid fermentation.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dfructooligosaccharides\u0026condition\u003Dibs'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

Fazit

Mixed results. Low doses may help (5 g) but higher doses can worsen bloating due to rapid fermentation.

Key Study Findings

Other

FODMAP Profile of Wholegrain Pasta.

Dose: None vs.: None Outcome: FODMAP compound content in pasta (analytical) Wirkung: None None

Population: Commercially available pasta products (analytical study)

Randomized Controlled Trial n=9 12 weeks

Modification of the Low FODMAP Diet Is Feasible in the Treatment of Irritable Bowel Syndrome: …

Dose: None vs.: Baseline; crossover between 3 diets Outcome: Birmingham IBS questionnaire symptom score Wirkung: 75% relief on low FOS+GOS; 62.5% on FODMAP p<0.05

Population: IBS patients (Rome IV criteria)

Other

Biotechnological Tools for the Production of Low-FODMAP Wholegrain Wheat and Rye Cookies and Crackers.

Dose: None vs.: Standard wholegrain flour products Outcome: FODMAP content reduction in cookies and crackers Wirkung: Up to 99.5% FODMAP reduction (wheat malt) None

Population: Laboratory food science study (no human subjects)

Randomized Controlled Trial 12 weeks Double-blind

Efficacy and Safety of a Mixture of Microencapsulated Sodium Butyrate, Probiotics, and Short Chain Fructooligosaccharides …

Dose: None vs.: Placebo Outcome: Quality of life Wirkung: None p = 0.023

Population: IBS patients

In Vitro

Microbial inulinase promotes fructan hydrolysis under simulated gastric conditions.

Dose: None vs.: None Outcome: None Wirkung: None None

Population: None

Controlled Clinical Trial n=54 3.0 weeks

[Clinical efficacy of a modern probiotic for the correction of intestinal microflora in patients with …

Dose: 350 mg vs.: None Outcome: IBS symptom improvement Wirkung: None None

Population: Irritable bowel syndrome with diarrhea and antibiotic-associated diarr

Key Statistics

Studien

150

Teilnehmer

↔

Mixed

Bewertung

Referenced Papers

FODMAP Profile of Wholegrain Pasta. Other

Foods (Basel, Switzerland) 2025 3 Zitierungen

Biotechnological Tools for the Production of Low-FODMAP Wholegrain Wheat and Rye Cookies and Crackers. Other

Foods (Basel, Switzerland) 2025 1 Zitierungen

Modification of the Low FODMAP Diet Is Feasible in the Treatment of Irritable Bowel Syndrome: A Randomised Crossover Study. Other

Gastroenterology research and … 2025

Efficacy and Safety of a Mixture of Microencapsulated Sodium Butyrate, Probiotics, and Short Chain Fructooligosaccharides in Patients with Irritable Bowel … Other

Journal of clinical … 2024 4 Zitierungen

Microbial inulinase promotes fructan hydrolysis under simulated gastric conditions. Other

Frontiers in nutrition 2023 8 Zitierungen

[Clinical efficacy of a modern probiotic for the correction of intestinal microflora in patients with irritable bowel syndrome with diarrhea … Other

Voprosy pitaniia 2023

Inulin as a functional ingredient and their applications in meat products. Review

Carbohydrate polymers 2022 77 Zitierungen

Increased fermentable carbohydrate intake alters colonic mucus barrier function through glycation processes and increased mast cell counts. Other

FASEB journal : … 2022 16 Zitierungen

Effects of Microencapsulated Sodium Butyrate, Probiotics and Short Chain Fructooligosaccharides in Patients with Irritable Bowel Syndrome: A Study Protocol of … Other

Journal of clinical … 2022 12 Zitierungen

A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effects of Multi-Strain Synbiotic in Patients with Functional Diarrhea and High Fecal … RCT

Nutrients 2022 8 Zitierungen

Current evidence on the therapeutic use of fiber in irritable bowel syndrome. Other

Expert review of … 2022 8 Zitierungen

Nutritional and anti-nutritional properties of lentil (Lens culinaris) protein isolates prepared by pilot-scale processing. Other

Food chemistry: X 2021 64 Zitierungen

FODMAP Fingerprinting of Bakery Products and Sourdoughs: Quantitative Assessment and Content Reduction through Fermentation. Other

Foods (Basel, Switzerland) 2021 10 Zitierungen

The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant … RCT

Nutrients 2020 78 Zitierungen

Impact of Cultivation Method and Cultivar Selection on Soluble Carbohydrates and Pungent Principles in Onions ( Allium cepa L.). Other

Journal of agricultural … 2018 13 Zitierungen

Effects of scFOS on the composition of fecal microbiota and anxiety in patients with irritable bowel syndrome: a randomized, double … RCT

Neurogastroenterology and motility 2017 131 Zitierungen

Gastrointestinal tolerance of low FODMAP oral nutrition supplements in healthy human subjects: a randomized controlled trial. RCT

Nutrition journal 2017 10 Zitierungen

[Contemporary dietotherapy of the irritable bowel syndrome]. Review

Voprosy pitaniia 2013

Efficacy, safety, and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome. RCT

The American journal … 2000 136 Zitierungen

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Übliche Dosierungen

general:: 2-10 g/day
prebioticeffect:: 5-8 g/day for bifidogenic effect
constipationsupport:: 5-10 g/day

Obergrenze: Well-tolerated up to 20 g/day; start low to avoid excess gas

In der Forschung untersuchte Dosierungen

Dosierung	Dauer	Wirkung	N
None	--	Neutral	--
None	12 weeks	Positive	9
None	--	Positive	--
None	12 weeks	Positive	--
None	--	Mixed	--
350 mg	3.0 weeks	Positive	54
None	--	Mixed	--
None	--	Negative	--

Beste Einnahmezeit: With meals; divide doses throughout the day

Safety & Side Effects

Gemeldete Nebenwirkungen

⚠ Gas, bloating, and flatulence (dose-dependent; more common above 10 g/day)
⚠ Abdominal cramping at higher doses
⚠ May worsen IBS symptoms in FODMAP-sensitive individuals
⚠ Loose stools at excessive doses

Bekannte Wechselwirkungen

● Other FODMAPs (cumulative fermentation effect in sensitive individuals)
● Blood sugar-lowering medications (FOS may modestly affect glycemic response)
● Calcium supplements (FOS may enhance calcium absorption)

Tolerierbare Höchstaufnahmemenge: Well-tolerated up to 20 g/day; start low to avoid excess gas

Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.

Frequently Asked Questions

Does Fructooligosaccharides (FOS) help with Irritable Bowel Syndrome (IBS)?

Based on 2 studies with 150 participants, there is preliminary evidence that needs more research that Fructooligosaccharides (FOS) may support Irritable Bowel Syndrome (IBS) management. Our evidence grade is D (Very Early Research).

How much Fructooligosaccharides (FOS) should I take for Irritable Bowel Syndrome (IBS)?

Studies have used various dosages. A commonly studied range is 2-10 g/day. Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of Fructooligosaccharides (FOS)?

Reported side effects may include Gas, bloating, and flatulence (dose-dependent; more common above 10 g/day), Abdominal cramping at higher doses, May worsen IBS symptoms in FODMAP-sensitive individuals, Loose stools at excessive doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for Fructooligosaccharides (FOS) and Irritable Bowel Syndrome (IBS)?

We rate the evidence as Grade D (Very Early Research). This rating is based on 2 peer-reviewed studies with 150 total participants. The overall direction of effect is mixed.

Related Evidence

Andere Inhaltsstoffe für Irritable Bowel Syndrome (IBS)

Peppermint Oil A Lactobacillus rhamnosus GG B Psyllium Husk B Lactobacillus plantarum B Partially Hydrolyzed Guar Gum (PHGG) B Bifidobacterium longum B

Fructooligosaccharides (FOS) für andere Beschwerden

Chronic Constipation C

Kurzfazit

Mixed results. Low doses may help (5 g) but higher doses can worsen bloating due to rapid fermentation.

Evidence Strength30%

Low confidence

Studienübersicht

RCT (5)Meta (0)Other (0)

Alternativen vergleichen

Sehen Sie, wie andere Inhaltsstoffe bei dieser Beschwerde abschneiden.

Alle Inhaltsstoffe ansehen für Irritable Bowel Syndrome (IBS)

Mehr erfahren

FDA-Haftungsausschluss: Diese Aussagen wurden nicht von der Food and Drug Administration bewertet. Die Produkte und Informationen auf dieser Website sind nicht dazu bestimmt, Krankheiten zu diagnostizieren, zu behandeln, zu heilen oder zu verhindern. Die dargestellten Evidenzbewertungen basieren auf unserer Analyse veröffentlichter begutachteter Forschung und stellen keine medizinische Beratung dar. Konsultieren Sie immer Ihren Arzt, bevor Sie mit der Einnahme von Nahrungsergänzungsmitteln beginnen.